BRWA
ABBV icon

B. Riley Wealth Advisors’s AbbVie ABBV Stock Holding History

B. Riley Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.19M Buy
32,220
+1,308
+4% +$281K 0.44% 49
2026
Q1 		$6.59M Sell
30,912
-6,592
-18% -$1.46M 0.42% 53
2025
Q4 		$8.57M Sell
37,504
-1,505
-4% -$343K 0.4% 45
2025
Q3 		$9.03M Sell
39,009
-3,199
-8% -$651K 0.42% 41
2025
Q2 		$7.83M Buy
+42,208
New +$7.84M 0.37% 46
2024
Q4 		$14.9M Sell
83,967
-2,133
-2% -$392K 0.49% 33
2024
Q3 		$16.9M Sell
86,100
-24,969
-22% -$4.66M 0.47% 36
2024
Q2 		$19.1M Sell
111,069
-34,343
-24% -$5.69M 0.48% 27
2024
Q1 		$21.7M Buy
145,412
+15,193
+12% +$2.62M 0.59% 32
2023
Q4 		$20.2M Sell
130,219
-15,193
-10% -$2.21M 0.54% 28
2023
Q3 		$21.7M Sell
145,412
-21,652
-13% -$3.18M 0.59% 32
2023
Q2 		$22.5M Sell
167,064
-15,708
-9% -$2.3M 0.51% 39
2023
Q1 		$29.1M Sell
182,772
-7,680
-4% -$1.17M 0.78% 15
2022
Q4 		$30.8M Buy
190,452
+5,860
+3% +$899K 0.86% 11
2022
Q3 		$24.8M Buy
184,592
+69,566
+60% +$9.98M 0.75% 19
2022
Q2 		$17.6M Sell
115,026
-12,824
-10% -$1.96M 0.74% 22
2022
Q1 		$20.7M Buy
127,850
+91
+0.1% +$13.2K 0.68% 19
2021
Q4 		$17.3M Buy
127,759
+1,982
+2% +$234K 0.5% 29
2021
Q3 		$13.6M Buy
125,777
+9,233
+8% +$1.06M 0.43% 41
2021
Q2 		$13.1M Buy
116,544
+8,349
+8% +$940K 0.43% 40
2021
Q1 		$11.7M Buy
108,195
+42,965
+66% +$4.6M 0.41% 42
2020
Q4 		$6.99M Sell
65,230
-15,247
-19% -$1.47M 0.37% 65
2020
Q3 		$7.07M Buy
80,477
+1,363
+2% +$128K 0.38% 64
2020
Q2 		$7.68M Buy
79,114
+13,970
+21% +$1.23M 0.51% 43
2020
Q1 		$4.96M Buy
65,144
+10,351
+19% +$882K 0.42% 53
2019
Q4 		$4.85M Buy
54,793
+11,120
+25% +$923K 0.41% 53
2019
Q3 		$3.31M Buy
43,673
+20,307
+87% +$1.39M 0.33% 66
2019
Q2 		$1.7M Buy
23,366
+803
+4% +$63.1K 0.19% 113
2019
Q1 		$1.82M Buy
22,563
+4,405
+24% +$360K 0.23% 98
2018
Q4 		$1.68M Sell
18,158
-1,896
-9% -$167K 0.24% 95
2018
Q3 		$1.9M Sell
20,054
-708
-3% -$67.1K 0.23% 98
2018
Q2 		$1.93M Buy
20,762
+703
+4% +$68.7K 0.25% 91
2018
Q1 		$1.9M Sell
20,059
-7,686
-28% -$844K 0.27% 95
2017
Q4 		$2.68M Buy
27,745
+1,554
+6% +$146K 0.36% 70
2017
Q3 		$2.33M Sell
26,191
-583
-2% -$44.4K 0.39% 62
2017
Q2 		$1.94M Buy
26,774
+389
+1% +$26.2K 0.35% 74
2017
Q1 		$1.72M Sell
26,385
-1,097
-4% -$69K 0.34% 75
2016
Q4 		$1.72M Buy
27,482
+1,317
+5% +$80.4K 0.35% 78
2016
Q3 		$1.26M Buy
26,165
+3,689
+16% +$239K 0.25% 102
2016
Q2 		$991K Sell
22,476
-237
-1% -$14.4K 0.2% 138
2016
Q1 		$924K Buy
22,713
+5,784
+34% +$322K 0.21% 116
2015
Q4 		$1M Sell
16,929
-2,238
-12% -$129K 0.2% 130
2015
Q3 		$1.04M Buy
19,167
+5,770
+43% +$376K 0.25% 105
2015
Q2 		$902K Sell
13,397
-634
-5% -$41.4K 0.22% 118
2015
Q1 		$821K Sell
14,031
-8,432
-38% -$509K 0.2% 137
2014
Q4 		$8.22K Buy
22,463
+10,595
+89% +$668K 0.18% 128
2014
Q3 		$685K Sell
11,868
-14,461
-55% -$803K 0.18% 153
2014
Q2 		$742K Buy
26,329
+13,204
+101% +$693K 0.17% 131
2014
Q1 		$675K Sell
13,125
-526
-4% -$26.6K 0.2% 118
2013
Q4 		$721K Buy
13,651
+4,343
+47% +$213K 0.23% 110
2013
Q3 		$416K Sell
9,308
-983
-10% -$43.6K 0.14% 164
2013
Q2 		$425K Buy
+10,291
New +$450K 0.14% 170

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

B. Riley Wealth Advisors's ABBV Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $281K and bringing the position to 32,220 shares worth $8.19M. The position accounts for 0.44% of the portfolio, ranked #49.

B. Riley Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.8M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • B. Riley Wealth Advisors held 32,220 shares of AbbVie worth $8.19M as of Q2 2026.
  • B. Riley Wealth Advisors bought 1,308 AbbVie shares in Q2 2026, an estimated $281K.
  • AbbVie made up 0.44% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #49 holding.
  • B. Riley Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • B. Riley Wealth Advisors's AbbVie position peaked at $30.8M in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.